The et al.46found that IL‐38 inhibited osteogenic activity in the aortic valve by inhibiting the NLRP3 inflammasome and caspase‐1, indicating that IL‐38 had the potential to prevent aortic valve calcification. The gene discussed is IL1F10; the disease is aortic valve calcification.